Kamada earnings were $20.4M for the trailing 12 months ending Mar 31, 2026, with 20.7% growth year over year. The latest KMDA earnings report on Mar 31, 2026 announced Q1 2026 earnings of $4.1M, up 16% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KMDA reported annual earnings of $20.2M, with 39.7% growth.
KMDA past earnings growth
How has KMDA's earnings growth performed historically?
On KMDA's earnings call on Invalid Date, Kamada (NASDAQ: KMDA) reported Q1 2026 earnings per share (EPS) of $0.07, up 0% year over year. Total KMDA earnings for the quarter were $4.13 million. In the same quarter last year, Kamada's earnings per share (EPS) was $0.07.
As of the last Kamada earnings report, Kamada is currently profitable. Kamada's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $20.37 million, a 26.8% increase year over year.
What was KMDA's earnings growth in the past year?
As of Kamada's earnings date in Invalid Date, Kamada's earnings has grown 20.69% year over year. This is 10.04 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 30.73%. KMDA earnings in the past year totalled $20.37 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.